AXGN Q2 2020 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$22M-17.2% YoY

Gross Profit

$17M74.7% margin

Operating Income

-$8M-37.3% margin

Net Income

-$8M-36.6% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-8.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$15M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$170M

Total Liabilities

$50M

Stockholders' Equity

$120M

Cash & Equivalents

$75M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$27M	-17.2%
Gross Profit	$17M	$22M	-26.5%
Operating Income	-$8M	-$8M	-7.6%
Net Income	-$8M	-$7M	-15.4%